Enlivex Therapeutics Current Cash

Enlivex Therapeutics (ENLV) currently reports a current cash of $2M as of December 2025. That compares with $3.4M in the prior-year period — down 41.2% year over year. Use the charts on this page to explore Enlivex Therapeutics's current cash history and peer comparisons.

Enlivex Therapeutics's current cash decreased from $3.4M to $2M — a 41.2% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Enlivex Therapeutics reported $2M in current cash as of December 2025. That compares with $3.4M in the prior-year period — down 41.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Enlivex Therapeutics, and consider following ENLV for alerts when major investors trade the stock.

Enlivex Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $2M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ENLV with unrelated industries.